ChemicalBook > Product Catalog >Biochemical Engineering >Inhibitors >PI3K / Akt / mTOR >PI3K inhibitor >TG 100713

TG 100713

TG 100713 Suppliers list
Company Name: ATK CHEMICAL COMPANY LIMITED
Tel: +undefined-21-51877795
Email: ivan@atkchemical.com
Products Intro: CAS:925705-73-3
Purity:98% HPLC Package:5MG;10MG;50MG;100MG,1G,5G
Company Name: Dideu Industries Group Limited
Tel: +86-29-89586680 +86-15129568250
Email: 1026@dideu.com
Products Intro: Product Name:TG 100713
CAS:925705-73-3
Purity:99.9% Package:25kgs/Drum;200kgs/Drum Remarks:FDA GMP CEP Approved Manufacturer
Company Name: Zhejiang J&C Biological Technology Co.,Limited
Tel: +1-2135480471 +1-2135480471
Email: sales@sarms4muscle.com
Products Intro: Product Name:TG100713 TG-100713 PI3K Inhibitor
CAS:925705-73-3
Purity:99% Package:5KG;1KG
Company Name: InvivoChem
Tel: +1-708-310-1919 +1-13798911105
Email: sales@invivochem.cn
Products Intro: Product Name:TG100713
CAS:925705-73-3
Purity:98% Package:5mg Remarks:V0142
Company Name: TargetMol Chemicals Inc.
Tel: +1-781-999-5354
Email: support@targetmol.com
Products Intro: Product Name:TG 100713;TG100713
CAS:925705-73-3
Package:10 mg;5 mg;50 mg Remarks:REAGENT;FOR LABORATORY USE ONLY
TG 100713 Basic information
Product Name:TG 100713
Synonyms:TG 100713;3-(2,4-DiaMino-6-pteridinyl)phenol;TG 100713,3-(2,4-DiaMino-6-pteridinyl)-phenol;Phenol, 3-(2,4-diamino-6-pteridinyl)-;TG100713;TG 100713;3-(2,4-Diaminopteridin-6-yl)phenol;TG100110;CS-577
CAS:925705-73-3
MF:C12H10N6O
MW:254.25
EINECS:
Product Categories:Inhibitors;Amines;Aromatics;Heterocycles;Intermediates & Fine Chemicals;Pharmaceuticals
Mol File:925705-73-3.mol
TG 100713 Structure
TG 100713 Chemical Properties
storage temp. Store at -20°C
solubility Limited solubility, soluble in DMSO
form solid
color Yellow
Safety Information
MSDS Information
TG 100713 Usage And Synthesis
UsesTG 100713 is an inhibitor of PI3-kinase. TG 100713 inhibits endothelial cell proliferation.
Biological Activitytg100713 is a pan-pi3k inhibitor against pi3kγ, pi3kδ, pi3kα and pi3kβ.pi3kγ and pi3kδ are a pair of pro-inflammatory pi3k isoforms that contribute to the inflammation that damages ischemia tissues upon reperfusion. phosphoinositide 3-kinases (pi3ks) are benefit to pro-cell survival roles during tissue iscg the reperfusion phhemia. therefore, it is possible that selectively inhibiting pro-inflammatory pi3k isoforms durinase could ultimately control overall tissue damage caused by ischemia/reperfusion injuries such as myocardial infarction.
in vitromodeling studies suggested that the freedom of conformational rotation permitted by ring substituents controls isoform selectivity. although substituent ring of tg100-115, tg100713, and tg101110 all require energy minima at 30–40°, angles diverge of each compound results in paying differing penalties from this range. tg100-115 displays the greatest barrier to rotation and finally is the most isoform selective, tg100713 has the most conformational flexibility (ring a being almost freely rotatable with maxima ≈5 kcal; 1 kcal = 4.18 kj), suggesting the least selective, and tg101110 lies an intermediate position (several conformations ≦10 but some >>50 kcal) [1].
in vivothe minimum structure which satisfies all three requirements is shown in tg100713, which so far has also displayed the best pi3k binding activity. interestingly, the sar profiles generating correlate quite well with the results of the initial in vivo screen further supports the involvement of pi3k as a target for inhibiting vascular permeability in related compounds [2].
IC 50(pi3kγ, pi3kδ, pi3kα and pi3kβ): 50 nm, 24 nm, 165 nm and 215 nm
references[1] doukas j, wrasidlo w, noronha g, dneprovskaia e, fine r, weis s, hood j, demaria a, soll r, cheresh d. phosphoinositide 3-kinase gamma/delta inhibition limits infarct size after myocardial ischemia/reperfusion injury. proc natl acad sci u s a. 2006 dec 26; 103(52):19866-71.
[2] palanki ms, dneprovskaia e, doukas j, fine rm, hood j, kang x, lohse d, martin m, noronha g, soll rm, wrasidlo w, yee s, zhu h. discovery of 3,3'-(2,4-diaminopteridine-6,7-diyl)diphenol as an isozyme-selective inhibitor of pi3k for the treatment of ischemia reperfusion injury associated with myocardial infarction. j med chem. 2007 sep 6;50(18):4279-94. epub 2007 aug 9.
TG 100713 Preparation Products And Raw materials
Tag:TG 100713(925705-73-3) Related Product Information
N-(1,1-Dimethylethyl)-3-[[5-methyl-2-[[4-(4-methyl-1-piperazinyl)phenyl]amino]-4-pyrimidinyl]amino]benzenesulfonamide Fedratinib TG-100-115 USP/EP/BP TG101209 USP/EP/BP Flumazenil 6-Thioguanine PIK-90 Afatinib ZSTK474 Canertinib